Germline CDH1 mutations confer a high lifetime risk of developing diffuse gastric (DGC) and
lobular breast cancer (LBC). A multidisciplinary workshop was organised to discuss genetic …

D2 procedure has been accepted in Far East as the standard treatment for both early (EGC)
and advanced gastric cancer (AGC) for many decades. Recently EGC has been successfully …

Background Endoscopic resection (ER) has been accepted as minimally invasive treatment
in patients with early gastric cancer (EGC) who have a negligible risk of lymph node …

Objective: To evaluate the safety and efficacy of laparoscopy-assisted distal gastrectomy
(LADG) in patients with early gastric cancer (EGC) to determine whether LADG is an …

Near-infrared fluorescence imaging with indocyanine green is an emerging technology
gaining clinical relevance in the field of oncosurgery. In recent decades, it has also been …

Objective: The purpose of this study was to evaluate the frequency of lymph node metastasis
according to the depth of tumor infiltration of the mucosa and submucosa. Background Data …

Objective: An accurate assessment of a potential lymph node metastasis is an important
issue for the appropriate treatment of early gastric cancer. Minimizing the amount of invasive …

Objective This study aims to answer the superiority of comparing laparoscopy-assisted distal
gastrectomy (LADG) with open distal gastrectomy (ODG) in the treatment early gastric …

Early gastric cancer (EGC) is an invasive carcinoma involving only the stomach mucosa or
submucosa, independently of lymph node status. EGC represents over 50% of cases in …

Background and study aim: Endoscopic submucosal dissection (ESD) of undifferentiated-
type early gastric cancer (UD-EGC) is technically feasible; however, the long-term clinical …